Abstract
Gradual changes in steady-state levels of beta amyloid peptides (Aβ) in the brain are considered as initial step in the amyloid cascade hypothesis of Alzheimers disease (AD). Aβ is a product of the secretase cleavage of the amyloid precursor protein and there is evidence that the membrane lipid environment may modulate secretase activity and alters its function. Aβ disturbs membrane properties of artificial and isolated biological membranes and of plasma membranes in living cells. Aβ induced changes in membrane fluidity could be explained by physico-chemical interactions of the peptide with membrane components such as cholesterol, phospholipids and gangliosides. Thus, cell membranes may be the location where the neurotoxic cascade of Aβ is initiated. Perturbation of membranes, binding to lipids and alteration of cellular calcium signaling by Aβ have been reported by several studies and these topics are examined in this review.
Keywords: Amyloid, membrane, membrane fluidity, cholesterol, ganglioside, Alzheimer, calcium, pyrene, diphenylhexatriene
Current Protein & Peptide Science
Title: Lipid Membranes and β-Amyloid: A Harmful Connection
Volume: 11 Issue: 5
Author(s): G.P. Eckert, W.G. Wood and W.E. Muller
Affiliation:
Keywords: Amyloid, membrane, membrane fluidity, cholesterol, ganglioside, Alzheimer, calcium, pyrene, diphenylhexatriene
Abstract: Gradual changes in steady-state levels of beta amyloid peptides (Aβ) in the brain are considered as initial step in the amyloid cascade hypothesis of Alzheimers disease (AD). Aβ is a product of the secretase cleavage of the amyloid precursor protein and there is evidence that the membrane lipid environment may modulate secretase activity and alters its function. Aβ disturbs membrane properties of artificial and isolated biological membranes and of plasma membranes in living cells. Aβ induced changes in membrane fluidity could be explained by physico-chemical interactions of the peptide with membrane components such as cholesterol, phospholipids and gangliosides. Thus, cell membranes may be the location where the neurotoxic cascade of Aβ is initiated. Perturbation of membranes, binding to lipids and alteration of cellular calcium signaling by Aβ have been reported by several studies and these topics are examined in this review.
Export Options
About this article
Cite this article as:
Eckert G.P., Wood W.G. and Muller W.E., Lipid Membranes and β-Amyloid: A Harmful Connection, Current Protein & Peptide Science 2010; 11 (5) . https://dx.doi.org/10.2174/138920310791330668
DOI https://dx.doi.org/10.2174/138920310791330668 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Conformational Changes of Prion Protein and Nucleic Acid Arising from their Interaction and Relation of the Altered Structures in Causing Prion Disease
Mini-Reviews in Medicinal Chemistry Polyamine Modulation of NMDARs as a Mechanism to Reduce Effects of Alcohol Dependence
Recent Patents on CNS Drug Discovery (Discontinued) Valproate and Neuroendocrine Changes in Relation to Women Treated for Epilepsy and Bipolar Disorder: A Review
Current Medicinal Chemistry Tumor Markers: The Potential of “Omics” Approach
Current Molecular Medicine <i>In Vitro</i> Cytotoxicity and Apoptosis Inducing Evaluation of Novel Halogenated Isatin Derivatives
Anti-Cancer Agents in Medicinal Chemistry Increased CRMP2 Phosphorylation is Observed in Alzheimers Disease; Does this Tell us Anything About Disease Development?
Current Alzheimer Research Cyclotron Production of PET Radiometals in Liquid Targets: Aspects and Prospects
Current Radiopharmaceuticals Illuminating microRNA Transcription from the Epigenome
Current Genomics Erythropoietin: Cytoprotection in Vascular and Neuronal Cells
Current Drug Targets - Cardiovascular & Hematological Disorders Immunological Mechanism and Clinical Application of PAMP Adjuvants
Recent Patents on Anti-Cancer Drug Discovery Histone Deacetylase Inhibitors in Cancer Treatment: A Review of the Clinical Toxicity and the Modulation of Gene Expression in Cancer Cells
Current Pharmaceutical Biotechnology The Role of Traditional Chinese Herbal Medicines and Bioactive Ingredients on Ion Channels: A Brief Review and Prospect
CNS & Neurological Disorders - Drug Targets Thiosemicarbazones as Potent Anticancer Agents and their Modes of Action
Mini-Reviews in Medicinal Chemistry Naturally-occurring Dimers of Flavonoids as Anticarcinogens
Anti-Cancer Agents in Medicinal Chemistry The Use of the Zebrafish Model to Aid in Drug Discovery and Target Validation
Current Topics in Medicinal Chemistry Hunting for Peptide Substrates of Prolyl Oligopeptidase: Classical Versus Non-Classical Bioactive Peptides
CNS & Neurological Disorders - Drug Targets Targeting Autophagy in the Brain: A Promising Approach?
Central Nervous System Agents in Medicinal Chemistry Heparin Oligosaccharides as Potential Therapeutic Agents in Senile Dementia
Current Pharmaceutical Design DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA
Current Pharmaceutical Design Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals
Current Gene Therapy